Australasian Anaesthesia 2011 - Australian and New Zealand ...

142 Australasian Anaesthesia 2011143REFERENCES1. Rodgers GM, Auerbach M, Cella D, Chertow GM, Coyne DW, Glaspy JA et al. High-Molecular Weight IronDextran: A Wolf in Sheep’s Clothing? J Am Soc Nephrol 2008; 19:833-840.2. Beattie WS, Karkouti K, Wijeysundera DN, Tait G. Risk associated with preoperative anemia in noncardiacsurgery: a single centre cohort study. Anesthesiology 2009; 110(3):574-581.3. Parischa SS, Flecknoe-Brown SC, Aleen KJ, Gibson PR, McMahon LP, Olynyk JK et al. Diagnosis andmanagement of iron deficiency anaemia: a clinical update. Med J Aust 2010; 193(9):525-532.4. Allen LH. Anemia and iron deficiency: effects on pregnancy outcomes. Am J Clin Nutr 2000; 71(5 Suppl):1280S-1284S.5. Grey DE, Finlayson J. Red cell transfusion for iron deficiency anaemia: a retrospective audit at a tertiary hospital.Vox Sang 2008; 94:138-142.6. Solomons NW, Schumann K. Intramuscular administration of iron dextran is inappropriate for treatment ofmoderate pregnancy anemia, both in intervention research on underprivileged women and in routine prenatalcare provided by public health services. Am J Clin Nutr 2004; 79:1-3.7. Danielson BG. Structure, Chemistry, and Pharmacokinetics of Intravenous Iron Agents. J Am Soc Nephrol2004; 15: S93-S98.8. Van Wyck DB. Labile Iron: Manifestations and Clinical Implications. J Am Soc Nephrol 2004; 15:S107-S111.9. Newnham E, Ahmad I, Thornton A, et al. Safety of iron polymaltose given as a total dose intravenous ironinfusion. Intern Med J 2006; 36:672-674.10. Auerbach M, Ballard H, Glaspy J. Clinical update: intravenous iron for anaemia. Lancet 2007; 369:1502-1504.11. Chertow GM, Mason PD, Vaaga-Nilsen O, Ahlmen J: Update on adverse drug events associated with parenteraliron. Nephrol Dial Transplant 2006; 21:378-382.12. Aronoff GR. Safety of Intravenous Iron in Clinical Practice: Implications for Anemia Management Protocols.J Am Soc Nephrol 2004; 15:S99-S106.13. Haines ML, Gibson PR. Delayed adverse reactions to total dose intravenous iron polymaltose. Intern MedJ 2009; 39:252-255.14. Auerbach M, Chaudhry M, Goldman H, Ballard H. Value of methylprednisolone in prevention of the arthralgiamyalgiasyndrome associated with the total dose infusion of iron dextran: A double blind randomized trial.J Lab Clin Med 1998; 131(3): 257-260.15. Van Wyck DB, Marten MG, Seid MH, Baker JB, Mangione A. Intravenous Ferric Carboxymaltose ComparedWith Oral Iron in the Treatment of Postpartum Anemia. A Randomized Controlled Trial. Obstet Gynecol2007;110:267-278.16. Khalafallah A, Dennis A, Bates J, Bates G, Robertson IK, Smith L et al. A prospective randomized, controlledtrial of intravenous versus oral iron for moderate iron deficiency anaemia of pregnancy. J Intern Med 2010;268:286-295.17. Beard JL. Effectiveness and strategies of iron supplementation during pregnancy. Am J Clin Nutr 2000;71: 1288S-94S.18. Beris P, Munoz M, Garcia-Erce JA, Thomas D, Maniatis A, Van der Linden P. Perioperative anaemia management:consensus statement on the role of intravenous iron. British Journal of Anaesthesia 2008; 100(5): 599-604.19. Kim YH, Chung HH, Kang SB, Kim SC, Kim YT. Safety and usefulness of intravenous iron sucrose in themanagement of preoperative anemia in patients with menorrhagia: a phase IV, open-label, prospective,randomized study. Acta Haematol 2009; 121(1):37-41.20. Edwards TJ, Noble EJ, Durran A, Mellor N, Hosie KB. Randomized clinical trial of preoperative intravenousiron sucrose to reduce blood transfusion in anaemic patients after colorectal surgery. British Journal of Surgery2009; 96:1122-1128.